The opposing roles of anti-angiogenic factors in cancer and preeclampsia

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 8, 2012, Pages 2652-2669

  Gilbert, Jeffrey S ^a   Bauer, Ashley J ^b   Gilbert, Sara A B ^b   Banek, Christopher T ^a  

^a UNIVERSITY OF OREGON   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Blood pressure; Cancer; Cardiovascular; Endothelial cells; Placenta; Preeclampsia; Pregnancy; Review; VEGF

Indexed keywords

ANGIOGENIC FACTOR; ARSENIC; ASBESTOS; BRCA1 PROTEIN; BRCA2 PROTEIN; C REACTIVE PROTEIN; CHROMIUM; CIGARETTE SMOKE; ENDOGLIN; ESTROGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HEME OXYGENASE 1; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PROGESTERONE; RADON; SILICON DIOXIDE; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

AMNION FLUID; ARTICLE; BODY MASS; BREAST CANCER; BREAST CELL; BRONCHUS CANCER; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL DIFFERENTIATION; DYSLIPOPROTEINEMIA; ENDOMETRIOSIS; ENDOMETRIUM CANCER; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FETUS DEVELOPMENT; GENE MUTATION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LUNG CANCER; MATERNAL AGE; MORBIDITY; MORTALITY; MULTIPLE PREGNANCY; NEOPLASM; NEWBORN MORBIDITY; NONHUMAN; NULLIPARA; OBESITY; OVARY CANCER; PATHOGENESIS; PATHOPHYSIOLOGY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY RATE; PROSTATE CANCER; PROTEINURIA; RISK FACTOR; UTERUS CANCER; VASCULAR ENDOTHELIUM;

EID: 84883579262     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e581     Document Type: Article

References (186)

1. Kelsey, Jennifer L., Gammon, Marilie D., and John, Esther M.: Reproductive Factors and Breast Cancer. Epidemiologic Reviews 15, 36-47 (1993))
2. Ekbom, A., Hsieh, C. C., Lipworth, L., Adami, H. Q., and Trichopoulos, D.: Intrauterine environment and breast cancer risk in women: a population- based study. Journal of the National Cancer Institute 89, 71-76 (1997)) (Pubitemid 26428080)
3. Troisi, R., Weiss, H. A., Hoover, R. N., Potischman, N., Swanson, C. A., Brogan, D. R., Coates, R. J., Gammon, M. D., Malone, K. E., Daling, J. R., and Brinton, L. A.: Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9, 641-647 (1998)) (Pubitemid 28476126)
4. Innes, K. E. and Byers, T. E.: Preeclampsia and breast cancer risk. Epidemiology 10, 722-732 (1999)) (Pubitemid 29494054)
5. Hubel, C. A., Snaedal, S., Ness, R. B., Weissfeld, L. A., Geirsson, R. T., Roberts, J. M., and Arngrimsson, R.: Dyslipoproteinaemia in postmenopausal women with a history of eclampsia. BJOG: An International Journal of Obstetrics and Gynaecology 107, 776-784 (2000)) (Pubitemid 30311915)
6. Innes, K. E. and Byers, T. E.: Smoking during pregnancy and breast cancer risk in very young women (United States). Cancer Causes Control 12, 179-185 (2001)) (Pubitemid 32165276)
7. Chambers, John C., Fusi, Luca, Malik, Iqbal S., Haskard, Dorian O., De Swiet, Michael, and Kooner, Jaspal S.: Association of Maternal Endothelial Dysfunction With Preeclampsia. JAMA: The Journal of the American Medical Association 285, 1607-1612 (2001)) (Pubitemid 32240253)
8. Wilson, Brenda J., Watson, M. Stuart, Prescott, Gordon J., Sunderland, Sarah, Campbell, Doris M., Hannaford, Philip, and Smith, W. Cairns: Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. British Medical Journal 326, 845-2003))
9. Innes, K. E. and Byers, T. E.: First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 112, 306-311 (2004)) (Pubitemid 39263739)
10. Cnattingius, Sven, Torrang, Anna, Ekbom, Anders, Granath, Fredrik, Petersson, Gunnar, and Lambe, Mats: Pregnancy Characteristics and Maternal Risk of Breast Cancer. JAMA: The Journal of the American Medical Association 294, 2474-2480 (2005)) (Pubitemid 41627925)
11. Wikstrom, Anna Karin, Haglund, Bengt, Olovsson, Matts, and Lindeberg, Solveig Norden: The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG: An International Journal of Obstetrics and Gynaecology 112, 1486-1491 (2005)) (Pubitemid 43961234)
12. Harskamp, R. E. and Zeeman, G. G.: Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 334, 291-295 (2007)) (Pubitemid 351339288)
13. Bellamy, Leanne, Casas, Juan Pablo, Hingorani, Aroon D., and Williams, David J.: Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335, 974-2007))
14. Gilbert, Jeffrey S., Nijland, Mark J., and Knoblich, Penny: Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections. Expert Review of Cardiovascular Therapy 6, 1367-1377 (2008))
15. Craici, Iasmina, Wagner, Steven, and Garovic, Vesna D.: Review: Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Therapeutic Advances in Cardiovascular Disease 2, 249-259 (2008))
16. Vikse, Bjorn Egil, Irgens, Lorentz M., Leivestad, Torbjorn, Skjaerven, Rolv, and Iversen, Bjarne M.: Preeclampsia and the Risk of End-Stage Renal Disease. The New England Journal of Medicine 359, 800-809 (2008))
17. McDonald, Sarah D., Malinowski, Ann, Zhou, Qi, Yusuf, Salim, and Devereaux, Philip J.: Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and metaanalyses. American Heart Journal 156, 918-930 (2008))
18. McDonald, Sarah D., Han, Zhen, Walsh, Michael W., Gerstein, Hertzel C., and Devereaux, Philip J.: Kidney Disease After Preeclampsia: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases 55, 1026-1039 (2010))
19. Gingery, Anne, Bahe, Emma L., and Gilbert, Jeffrey S.: Placental ischemia and breast cancer risk after preeclampsia: tying the knot. Expert Review of Anticancer Therapy 9, 671-681 (2009))
20. agaard-Tillery, Kjersti M., Stoddard, Gregory J., Holmgren, Calla, Lacoursiere, D. Yvette, Fraser, Alison, Mineau, Geraldine P., and Varner, Michael W.: Preeclampsia and subsequent risk of cancer in Utah. American Journal of Obstetrics and Gynecology 195, 691-699 (2006)) (Pubitemid 44389706)
21. Polednak, A. P. and Janerich, D. T.: Characteristics of 1St Pregnancy in Relation to Early Breast-Cancer - A Case-Control Study. Journal of Reproductive Medicine 28, 314-318 (1983)) (Pubitemid 13098695)
22. Innes, K., Byers, T., and Schymura, M.: Birth characteristics and subsequent risk for breast cancer in very young women. Am J Epidemiol 152, 1121-1128 (2000)) (Pubitemid 32005749)
23. Vatten, L. J., Forman, M. R., Nilsen, T. I. L., Barrett, J. C., and Romundstad, P. R.: The negative association between preeclampsia and breast cancer risk may depend on the offspring's gender. Br J Cancer 96, 1436-1438 (2007)) (Pubitemid 46685775)
24. Pettersson, Andreas, Richiardi, Lorenzo, Cnattingius, Sven, Kaijser, Magnus, and Akre, Olof: Gestational Hypertension, Preeclampsia, and Risk of Testicular Cancer. Cancer Research 68, 8832-8836 (2008))
25. Forman, Michele R., Cantwell, Marie M., Ronckers, C. +, and Zhang, Yawei: Through the Looking Glass at Early-Life Exposures and Breast Cancer Risk. Cancer Investigation 23, 609-624 (2005)) (Pubitemid 43286663)
26. Lambe, M., Hsieh, C., Trichopoulos, D., Ekbom, A., Pavia, M., and Adami, H. O.: Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331, 5-9 (1994)) (Pubitemid 24195593)
27. Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, J. T., and Hoel, D. G.: 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303, 767-770 (1983)) (Pubitemid 13054488)
28. MacMahon, B., Cole, P., Lin, T. M., Lowe, C. R., Mirra, A. P., Ravnihar, B., Salber, E. J., Valaoras, V. G., and Yuasa, S.: Age at first birth and breast cancer risk. Bull World Health Organ 43, 209-221 (1970))
29. Mogren, I., Stenlund, H., and Hogberg, U.: Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncol 40, 849-854 (2001)) (Pubitemid 34082732)
30. Russo, J., Mailo, D., Hu, Y. F., Balogh, G., Sheriff, F., and Russo, I. H.: Breast differentiation and its implication in cancer prevention. Clin Cancer Res 11, 931s-936s (2005)) (Pubitemid 40111108)
31. Calderon-Margalit, Ronit, Friedlander, Yechiel, Yanetz, Rivka, Deutsch, Lisa, Perrin, Mary C., Kleinhaus, Karine, Tiram, Efrat, Harlap, Susan, and Paltiel, Ora: Preeclampsia and subsequent risk of cancer: update from the Jerusalem Perinatal Study. American Journal of Obstetrics and Gynecology 63, e1-5 (2009))
32. Mogren, I., Stenlund, H., and Hogberg, U.: Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncol 40, 849-854 (2001)) (Pubitemid 34082732)
33. Paltiel, Ora, Friedlander, Yehiel, Tiram, Efrat, Barchana, Micha, Xue, Xiaonan, and Harlap, Susan: Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort. BMJ 328, 919 (2004))
34. Colson, Drew, Verzwyvelt, Joseph D., Arany, Marietta, Ojeda, Norma, and Gilbert, Jeffrey S.: Endothelial dysfunction after hypertensive pregnancy in the rat. The FASEB Journal 23, 969 (2009))
35. Gilbert, Jeffrey S., Babcock, Sara A., and Granger, Joey P.: Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression. Hypertension 50, 1142-1147 (2007)) (Pubitemid 350172938)
36. Gilbert, Jeffrey S., Gilbert, Sara A. B., Arany, Marietta, and Granger, Joey P.: Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin Expression. Hypertension 53, 399-403 (2008))
37. Makris, A., Thornton, C., Thompson, J., Thomson, S., Martin, R., Ogle, R., Waugh, R., McKenzie, P., Kirwan, P., and Hennessy, A.: Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 71, 977-984 (2007)) (Pubitemid 46741987)
38. Maynard, Sharon E., Min, Jiang Yong, Merchan, Jaime, Lim, Kee Hak, Li, Jianyi, Mondal, Susanta, Libermann, Towia A., Morgan, James P., Sellke, Frank W., Stillman, Isaac E., Epstein, Franklin H., Sukhatme, Vikas P., and Karumanchi, S. Ananth: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigation 111, 649-658 (2003)) (Pubitemid 36278583)
39. Mutter, Walter P. and Karumanchi, S. Ananth: Molecular mechanisms of preeclampsia. Microvascular Research 75, 1-8 (2008)) (Pubitemid 350266733)
40. Venkatesha, S., Toporsian, M., Lam, C., Hanai, J., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K. H., Yuan, H. T., Libermann, T. A., Stillman, I. E., Roberts, D., D'Amore, P. A., Epstein, F. H., Sellke, F. W., Romero, R., Sukhatme, V. P., Letarte, M., and Karumanchi, S. A.: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12, 642-649 (2006)) (Pubitemid 43865232)
41. Maynard, Sharon, Epstein, Franklin H., and Karumanchi, S. Ananth: Preeclampsia and Angiogenic Imbalance. Annual Review of Medicine 59, 61-78 (2008)) (Pubitemid 351287924)
42. Sibai, B., Dekker, G., and Kupferminc, M.: Preeclampsia. Lancet 365, 785-799 (2005))
43. Roberts, James M., Pearson, Gail, Cutler, Jeff, and Lindheimer, Marshall: Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 41, 437-445 (2003)) (Pubitemid 36314613)
44. Gilbert, Jeffrey S., Ryan, Michael J., LaMarca, Babbette B., Sedeek, Mona, Murphy, Sydney R., and Granger, Joey P.: Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. AJP - Heart and Circulatory Physiology 294, H541-H550 (2008)) (Pubitemid 351253261)
45. Jacquemyn, Y. and Zemtsova, O.: Risk factors and prediction of preeclampsia. Acta Clin Belg 65, 1-12 (2010))
46. Duckitt, K. and Harrington, D.: Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ 330, 565 (2005))
47. Weissgerber, T. L., Wolfe, L. A., and Davies, G. A.: The role of regular physical activity in preeclampsia prevention. Med Sci Sports Exerc 36, 2024-2031 (2004)) (Pubitemid 39612842)
48. Yeo, S., Steele, N. M., Chang, M. C., Leclaire, S. M., Ronis, D. L., and Hayashi, R.: Effect of exercise on blood pressure in pregnant women with a high risk of gestational hypertensive disorders. J Reprod Med 45, 293-298 (2000)) (Pubitemid 30238161)
49. Banek, Christopher T., Johnson, Britt K., Gingery, Anne, Bauer, Ashley J., and Gilbert, Jeffrey S.: Exercise training attenuates placental ischemia induced hypertension and angiogenic imbalance in the rat. The FASEB Journal 25, 836 (2011))
50. Falcao, S., Bisotto, S., Michel, C., Lacasse, A. A., Vaillancourt, C., Gutkowska, J., and Lavoie, J. L.: Exercise training can attenuate preeclampsia-like features in an animal model. J Hypertens (2010))
51. Weissgerber, Tracey L., Davies, Gregory A. L., and Roberts, James M.: Modification of angiogenic factors by regular and acute exercise during pregnancy. Journal of Applied Physiology 108, 1217-1223 (2010))
52. Triche, E. W., Grosso, L. M., Belanger, K., Darefsky, A. S., Benowitz, N. L., and Bracken, M. B.: Chocolate consumption in pregnancy and reduced likelihood of preeclampsia. Epidemiology 19, 459-464 (2008)) (Pubitemid 351543525)
53. Jeyabalan, A., Powers, R. W., Durica, A. R., Harger, G. F., Roberts, J. M., and Ness, R. B.: Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens 21, 943-947 (2008))
54. Dumitrescu, R. G. and Cotarla, I.: Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 9, 208-221 (2005))
55. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M. J.: Cancer statistics, 2009. CA Cancer J Clin 59, 225-249 (2009))
56. Yancik, R.: Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 71, 517-523 (1993)) (Pubitemid 23021245)
57. Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., and Brody, L. C.: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11, 198-200 (1995))
58. King, M. C., Marks, J. H., and Mandell, J. B.: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302, 643-646 (2003)) (Pubitemid 37310920)
59. Brody, Julia Green, Rudel, Ruthann A., Michels, Karin B., Moysich, Kirsten B., Bernstein, Leslie, Attfield, Kathleen R., and Gray, Sharon: Environmental pollutants, diet, physical activity, body size, and breast cancer. Cancer 109, 2627-2634 (2007))
60. American Cancer Society: Surveillance and Health Policy Research (2010))
61. Brody, J. G., Rudel, R. A., Michels, K. B., Moysich, K. B., Bernstein, L., Attfield, K. R., and Gray, S.: Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention? Cancer 109, 2627-263 (2007))
62. Petracci, E., Decarli, A., Schairer, C., Pfeiffer, R. M., Pee, D., Masala, G., Palli, D., and Gail, M. H.: Risk Factor Modification and Projections of Absolute Breast Cancer Risk. J Natl Cancer Inst (2011))
63. Greenlee, R. T., Murray, T., Bolden, S., and Wingo, P. A.: Cancer statistics, 2000. CA Cancer J Clin 50, 7-33 (2000)) (Pubitemid 30072093)
64. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M. D., Struewing, J., Arason, A., Scherneck, S., Peto, J., Rebbeck, T. R., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B. A., Gayther, S. A., Zelada-Hedman, M., and.: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62, 676-689 (1998)) (Pubitemid 28164626)
65. Hecht, S. S.: Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg 391, 603-613 (2006)) (Pubitemid 44657742)
66. Vatten, L. J., Romundstad, P. R., Trichopoulos, D., and Skjaerven, R.: Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 87, 971-973 (2002)) (Pubitemid 35305647)
67. Paltiel, O., Friedlander, Y., Tiram, E., Barchana, M., Xue, X., and Harlap, S.: Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort. BMJ 328, 919 (2004))
68. Freeman, Dilys J., McManus, Frances, Brown, Elizabeth Ann, Cherry, Lynne, Norrie, John, Ramsay, Jane E., Clark, Peter, Walker, Isobel D., Sattar, Naveed, and Greer, Ian A.: Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia. Hypertension 44, 708-714 (2004)) (Pubitemid 39435242)
69. Hubel, C. A., Wallukat, G., Wolf, M., Herse, F., Rajakumar, A., Roberts, J. M., Markovic, N., Thadhani, R., Luft, F. C., and Dechend, R.: Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 49, 612-617 (2007))
70. Hubel, Carl A., Powers, Robert W., Snaedal, Sunna, Gammill, Hilary S., Ness, Roberta B., Roberts, James M., and Arngrimsson, Reynir: C-Reactive Protein Is Elevated 30 Years After Eclamptic Pregnancy. Hypertension 51, 1499-1505 (2008))
71. Wolf, Myles, Hubel, Carl A., Lam, Chun, Sampson, Marybeth, Ecker, Jeffrey L., Ness, Roberta B., Rajakumar, Augustine, Daftary, Ashi, Shakir, Alia S. M., Seely, Ellen W., Roberts, James M., Sukhatme, Vikas P., Karumanchi, S. Ananth, and Thadhani, Ravi: Preeclampsia and Future Cardiovascular Disease: Potential Role of Altered Angiogenesis and Insulin Resistance. Journal of Clinical Endocrinology Metabolism 89, 6239-6243 (2004)) (Pubitemid 39628439)
72. Thompson, W. Douglas, Jacobson, Herbert I., Negrini, Bryan, and Janerich, Dwight T.: Hypertension, Pregnancy, and Risk of Breast Cancer. JNCI Journal of the National Cancer Institute 81, 1571-1574 (1989)) (Pubitemid 19253306)
73. Terry, Mary Beth, Perrin, Mary, Salafia, Carolyn M., Zhang, Fang Fang, Neugut, Alfred I., Teitelbaum, Susan L., Britton, Julie, and Gammon, Marilie D.: Preeclampsia, Pregnancy-related Hypertension, and Breast Cancer Risk. American Journal of Epidemiology 165, 1007-1014 (2007)) (Pubitemid 46598830)
74. Troisi, R., Innes, K. E., Roberts, J. M., and Hoover, R. N.: Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role? Br J Cancer 97, 688-690 (2007)) (Pubitemid 47339891)
75. Xue, F. and Michels, K. B.: Intrauterine factors and risk of breast cancer: a systematic review and metaanalysis of current evidence. Lancet Oncol 8, 1088-1100 (2007)) (Pubitemid 350192898)
76. Cohn, Barbara A., Cirillo, Piera M., Christianson, Roberta E., van den Berg, Barbara J., and Siiteri, Pentii K.: Placental Characteristics and Reduced Risk of Maternal Breast Cancer. JNCI Journal of the National Cancer Institute 93, 1133-1140 (2001)) (Pubitemid 32780964)
77. Gingery, Anne and Gilbert, Jeffrey S.: Anti-Proliferative Effects of Sera from Rats with Placental Ischemia on Breast Cancer Cells. The FASEB Journal 23, 984 (2009))
78. Gingery, Anne, Nelson, Adam M., Soldner, Emma L. B., and Gilbert, Jeffrey S.: Soluble endoglin inhibits breast cancer cell proliferation. The FASEB Journal 24, 816 (2010))
79. Nelson, Adam Michael, Gingery, Anne, Soldner, Emma L. B., and Gilbert, Jeffrey S.: Vascular endothelial growth factor antagonism inhibits breast cancer proliferation via Akt and Erk signaling. The FASEB Journal 24, 816 (2010))
80. Gu, J. W., Young, E., Busby, B., Covington, J., Tan, W., and Johnson, J. W.: Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis and growth of breast cancer in female mice. Cancer Biol Ther 8, (2009))
81. Young, E., Miele, L., Tucker, K. B., Huang, M., Wells, J., and Gu, J. W.: SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells. Cancer Biol Ther 10, 703-711 (2010))
82. Gilbert, J. S., Cox, L. A., Mitchell, G., and Nijland, M. J.: Nutrient-restricted fetus and the cardio-renal connection in hypertensive offspring. Expert Rev Cardiovasc Ther 4, 227-237 (2006))
83. Gilbert, Jeffrey S. and Nijland, Mark J.: Sex differences in the developmental origins of hypertension and cardiorenal disease. AJP - Regulatory, Integrative and Comparative Physiology 295, R1941-R1952 (2008))
84. Tamimi, R., Lagiou, P., Vatten, L. J., Mucci, L., Trichopoulos, D., Hellerstein, S., Ekbom, A., Adami, H. O., and Hsieh, C. C.: Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev 12, 647-650 (2003)) (Pubitemid 36899846)
85. Trichopoulos, D., Adami, H. O., Ekbom, A., Hsieh, C. C., and Lagiou, P.: Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer 122, 481-485 (2008)) (Pubitemid 350308937)
86. Lagiou, P., Hsieh, C. C., Trichopoulos, D., Adami, H. O., Hall, P., Chie, L., and Ekbom, A.: Neonatal growth and breast cancer risk in adulthood. Br J Cancer 99, 1544-1548 (2008))
87. Gingery, Anne, Johnson, Britt K., and Gilbert, Jeffrey S.: Fetal Growth Restriction Results in Increased Mammary Tumor Development. The FASEB Journal 25, 851 (2011))
88. Fisher, S. J. and Roberts JM: Defects in Placentation and Placental Perfusion. 2nd, 377-394 (1999))
89. Conrad, K. P. and Benyo, D. F.: Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37, 240-249 (1997)) (Pubitemid 27149786)
90. Alam J, Shibahara S, and Smith A: Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. J Biol Chem 264, 6371-6375 (1989)) (Pubitemid 19106717)
91. Motterlini R, Foresti R, Bassi R, Calabrese V, Clark JE, and Green CJ: Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem 275, 13613-13620 (2000)) (Pubitemid 30257429)
92. Keyse SM, Applegate LA, Tromvoukis Y, and Tyrell RM: Oxidant stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblasts. Mol Cell Biol 10, 4967-4969 (1990))
93. Zhang M, Zhang BH, Chen L, and An W: Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation. Cell Res 12, 123-132 (2002)) (Pubitemid 135708320)
94. Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, Lewis RK, Li Q, Rokosh DG, Ford R, Spiinale FG, Riggs DW, Srivastava S, Bhatnagar A, Bolli R, and Prabhu SD: Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 121, 1912-1925 (2010))
95. Prestera T, Talalay P, Alam J, Ahn YI, Lee PJ, and Choi AM: arallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol Med 1, 827-837 (1995)) (Pubitemid 3013090)
96. Angermayr B, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J, and Fernandez M: Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in poral hypertensive rats. J Hepatol 44, 1033-1039 (2006))
97. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, and Nabel EG: Heme oxygenase-1 protects against vascukar constriction and proliferation. Nat Med 6, 693-698 (2001)) (Pubitemid 32588025)
98. Ahmed, A., Rahman, M., Zhang, X., Acevedo, C. H., Nijjar, S., Rushton, I., Bussolati, B., and St, John J.: Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 6, 391-409 (2000))
99. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, and Vercellotti GM: Ferritin: a cytoprotective antioxidant strategem of endothlium. J Biol Chem 267, 18148-18153 (1992))
100. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046 (1987)) (Pubitemid 17049750)
101. Sarady-Andrews JK, Liu F, Gallo D, Nakao A, Overhaus M, Ollinger R, Choi AM, and Otterbein LE: Biliverdin administration protects against endotoxininduced acute lung injury in rats. AJP: Am J Physiol Lung Cell Mol Physiol 289, 1131-1137 (2005))
102. Baranano DE, Rao M, Ferris CD, and Snyder SH: Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99, 16093-16098 (2002)) (Pubitemid 35462754)
103. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, and Choi AM: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6, 422-428 (2000)) (Pubitemid 30208159)
104. Sass G, Soares MC, Yamashita K, Seyfried S, Zimmermann WH, Eschenhagen T, Kaczmarek E, Ritter T, Volk HD, and Tiegs G: Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology 38, 909-918 (2003)) (Pubitemid 37221674)
105. Morita T, Mitsialis SA, Koike H, Liu Y, and Kourembanas S: Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272, 32804-32809 (1997)) (Pubitemid 28023614)
106. Ahmed, A., Rahman, M., Zhang, X., Acevedo, C. H., Nijjar, S., Rushton, I., Bussolati, B., and St, John J.: Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 6, 391-409 (2000))
107. Barber A, Robson SC, Myatt L, Bulmer JN, and Lyall F: Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction. FASEB 15, 1158-1168 (2001)) (Pubitemid 32436301)
108. Lash GE, McLaughlin BE, MacDonald-Goodfellow SK, Smith GN, Brien JF, Marks GS, Nakatsu K, and Graham CH: Relationship between tissue damage and heme oxygenase expression in chorionic villi of term human placenta. Am J Physiol Heart Circ Physiol 284, 160-167 (2003))
109. George, E. M., Cockrell, K., Aranay, M., Csongradi, E., Stec, D. E., and Granger, J. P.: Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 57, 941-948 (2011))
110. Ahmed A and Cudmore MJ: Can the biology of VEGF and haem oxygenases help solve pre-eclampsia. Biochem Soc Trans 37, 1237-1242 (2009))
111. Cudmore MJ, Ahmad S, Al-Ani B, Fujisawa T, Coxall G, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, and Ahmed A: Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115, 1789-1797 (2007)) (Pubitemid 46648616)
112. Wolf, M., Shah, A., Lam, C., Martinez, A., Smirnakis, K. V., Epstein, F. H., Taylor, R. N., Ecker, J. L., Karumanchi, S. A., and Thadhani, R.: Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol 193, 16-22 (2005)) (Pubitemid 40991821)
113. Thadhani, R., Mutter, W. P., Wolf, M., Levine, R. J., Taylor, R. N., Sukhatme, V. P., Ecker, J., and Karumanchi, S. A.: First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 89, 770-775 (2004)) (Pubitemid 38269892)
114. Shibata, E., Rajakumar, A., Powers, R. W., Larkin, R. W., Gilmour, C., Bodnar, L. M., Crombleholme, W. R., Ness, R. B., Roberts, J. M., and Hubel, C. A.: Soluble fmslike tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 90, 4895-4903 (2005)) (Pubitemid 41159388)
115. Rajakumar, A., Michael, H. M., Rajakumar, P. A., Shibata, E., Hubel, C. A., Karumanchi, S. A., Thadhani, R., Wolf, M., Harger, G., and Markovic, N.: Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 26, 563-573 (2005)) (Pubitemid 40916309)
116. Levine, R. J., Maynard, S. E., Qian, C., Lim, K. H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., Sibai, B. M., Sukhatme, V. P., and Karumanchi, S. A.: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350, 672-683 (2004)) (Pubitemid 38364626)
117. Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., Sibai, B. M., Epstein, F. H., Romero, R., Thadhani, R., and Karumanchi, S. A.: Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355, 992-1005 (2006)) (Pubitemid 44343543)
118. Lam, C., Lim, K. H., and Karumanchi, S. A.: Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46, 1077-1085 (2005)) (Pubitemid 41533005)
119. Abid, M, Schoots, I., Spokes, K., Wu, S, Mawhinney, C, and Aird, W.: Vascular Endothelial Growth Factormediated Induction of Manganese Superoxide Dismutase Occurs through Redox-dependent Regulation of Forkhead and I{kappa}B/NF-{kappa}B. Journal of Biological Chemistry 279, 44030-44038 (2004)) (Pubitemid 39390712)
120. Abid, M., Tsai, J., Spokes, K., Deshpande, S., Irani, K., and Aird, W.: Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidasedependent mechanism. The FASEB Journal 15, 2548-2550 (2001))
121. Maynard, S. E., Venkatesha, S., Thadhani, R., and Karumanchi, S. A.: Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res 57, 1R-7R (2005)) (Pubitemid 40593239)
122. Karumanchi, S. A. and Bdolah, Y.: Hypoxia and sFlt- 1 in preeclampsia: the "chicken-and-egg" question. Endocrinology 145, 4835-4837 (2004)) (Pubitemid 39551099)
123. Tsatsaris, Vassilis, Goffin, Frederic, Munaut, Carine, Brichant, Jean Francois, Pignon, Marie Rose, Noel, Agnes, Schaaps, Jean Pierre, Cabrol, Dominique, Frankenne, Francis, and Foidart, Jean Michel: Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences. Journal of Clinical Endocrinology Metabolism 88, 5555-5563 (2003)) (Pubitemid 37452769)
124. Lu, Fangxian, Longo, Monica, Tamayo, Esther, Maner, William, Al-Hendy, Ayman, Anderson, Garland D., Hankins, Gary D. V., and Saade, George R.: The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. American Journal of Obstetrics and Gynecology 196, 396-396 (2007))
125. Vuorela, P., Helske, S., Hornig, C., Alitalo, K., Weich, H., and Halmesmaki, E.: Amniotic Fluid-Soluble Vascular Endothelial Growth Factor Receptor-1 in Preeclampsia. Obstetrics Gynecology 95, 353-357 (2000)) (Pubitemid 30100498)
126. Kendall, R. L., Wang, G., and Thomas, K. A.: Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226, 324-328 (1996)) (Pubitemid 26331903)
127. Bridges, Jason P., Gilbert, Jeffrey S., Colson, Drew, Gilbert, Sara A., Dukes, Matthew P., Ryan, Michael J., and Granger, Joey P.: Oxidative Stress Contributes to Soluble Fms-Like Tyrosine Kinase-1 Induced Vascular Dysfunction in Pregnant Rats. Am J Hypertens 22, 564-568 (2009))
128. Masuyama, H., Nakatsukasa, H., Takamoto, N., and Hiramatsu, Y.: Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. J Clin Endocrinol Metab 92, 2672-2679 (2007)) (Pubitemid 47037375)
129. Jerkic, Mirjana, Rivas-Elena, Juan V., Prieto, Marta, Carron, Rosalia, Sanz-Rodriguez, Francisco, Perez-Barriocanal, Fernando, Rodriguez-Barbero, Alicia, Bernabeu, Carmelo, and Lopez-Novoa, J. M.: Endoglin regulates nitric oxide-dependent vasodilatation. The FASEB Journal 03-0197fje (2004))
130. Gu, Yang, Lewis, David F., and Wang, Yuping: Placental Productions and Expressions of Soluble Endoglin, Soluble fms-Like Tyrosine Kinase Receptor-1, and Placental Growth Factor in Normal and Preeclamptic Pregnancies. Journal of Clinical Endocrinology Metabolism 93, 260-266 (2008))
131. Perticone, Francesco, Sciacqua, Angela, Perticone, Maria, Laino, Irma, Miceli, Sofia, Care', Ilaria, Galiano Leone, Giulia, Andreozzi, Francesco, Maio, Raffaele, and Sesti, Giorgio: Low-Plasma Insulin-Like Growth Factor-I Levels Are Associated with Impaired Endothelium-Dependent Vasodilatation in a Cohort of Untreated, Hypertensive Caucasian Subjects. Journal of Clinical Endocrinology Metabolism 93, 2806-2810 (2008)) (Pubitemid 352008555)
132. Tivesten, A., Bollano, E., Andersson, I., Fitzgerald, S., Caidahl, K., Sjogren, K., Skott, O., Liu, J. L., Mobini, R., Isaksson, O. G., Jansson, J. O., Ohlsson, C., Bergstrom, G., and Isgaard, J.: Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology 143, 4235-4242 (2002)) (Pubitemid 35239553)
133. Pete, G., Hu, Y., Walsh, M., Sowers, J., and Dunbar, J. C.: Insulin-like growth factor-I decreases mean blood pressure and selectively increases regional blood flow in normal rats. Proc Soc Exp Biol Med 213, 187-192 (1996))
134. Walsh, M. F., Barazi, M., Pete, G., Muniyappa, R., Dunbar, J. C., and Sowers, J. R.: Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 137, 1798-1803 (1996)) (Pubitemid 26133956)
135. Tsukahara, H., Gordienko, D. V., Tonshoff, B., Gelato, M. C., and Goligorsky, M. S.: Direct demonstration of insulinlike growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 45, 598-604 (1994)) (Pubitemid 24065099)
136. Cooley, S. M., Donnelly, J. C., Geary, M. P., Rodeck, C. H., and Hindmarsh, P. C.: Maternal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGF BP-3 and the hypertensive disorders of pregnancy. J Matern Fetal Neonatal Med 23, 658-661 (2010))
137. Vatten, L. J., Nilsen, T. I., Juul, A., Jeansson, S., Jenum, P. A., and Eskild, A.: Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur J Endocrinol 158, 101-105 (2008)) (Pubitemid 351211046)
138. Hubinette, A., Lichtenstein, P., Brismar, K., Vatten, L., Jacobsen, G., Ekbom, A., and Cnattingius, S.: Serum insulinlike growth factors in normal
139. Ning, Y., Williams, M. A., Vadachkoria, S., Muy-Rivera, M., Frederick, I. O., and Luthy, D. A.: Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia. Clin Biochem 37, 968-973 (2004)) (Pubitemid 39388657)
140. Ingec, M., Gursoy, H. G., Yildiz, L., Kumtepe, Y., and Kadanali, S.: Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 84, 214-219 (2004)) (Pubitemid 38314761)
141. Heltemes, A., Gingery, A., Soldner, Emma L. B., Bozadjieva, N., Jahr, KN, Johnson, B., and Gilbert, J. S.: Chronic placental ischemia alters amniotic fluid milieu and results in impaired glucose tolerance, insulin resistance and hyperleptinemia in young rats. Experimental Biology and Medicine 235, 892-899 (2010))
142. Was, H., Dulak, J., and Jozkowicz, A.: Heme oxygenase-1 in tumor biology and therapy. Curr Drug Targets 11, 1551-1570 (2010))
143. Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, Shibahara S, Ogawa M, and Maeda H: Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer 80, 1945-1954 (1999)) (Pubitemid 29391278)
144. Tanaka S, Akaike T, Fang J, Beppu T, Ogawa M, Tamura F, Miyamoto Y, and Maeda H: Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour. Br J Cancer 88, 902-909 (2003)) (Pubitemid 36520878)
145. Was H, Cichon T, Smolarczyk R, Rudnicka D, Stopa M, Chevalier C, Leger JJ, Lackowska B, Grochot A, Bojkowska K, Ratjska A, Kieda C, Szala S, Dulak J, and Jozkowicz A: Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 169, 2181-2198 (2006)) (Pubitemid 351181977)
146. Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Kunzli B, Autschbach F, Meuer S, Buchler MW, and Friess H: Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 11, 3790-3798 (2005)) (Pubitemid 40685598)
147. Tsuji, M. H., Yanagawa, T., Iwasa, S., Tabuchi, K., Onizawa, K., Bannai, S., Toyooka, H., and Yoshida, H.: Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Lett 138, 53-59 (1999)) (Pubitemid 29189184)
148. Liu, Z. M., Chen, G. G., Ng, E. K., Leung, W. K., Sung, J. J., and Chung, S. C.: Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene 23, 503-513 (2004)) (Pubitemid 38175005)
149. Li, M. Y., Yip, J., Hsin, M. K., Mok, T. S., Wu, Y., Underwood, M. J., and Chen, G. G.: Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis. Eur Respir J 32, 911-923 (2008))
150. Li, Y., Su, J., DingZhang, X., Zhang, J., Yoshimoto, M., Liu, S., Bijian, K., Gupta, A., Squire, J. A., Alaoui Jamali, M. A., and Bismar, T. A.: PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome. J Pathol 224, 90-100 (2011))
151. Liu, Y., Liang, Y., Zheng, T., Yang, G., Zhang, X., Sun, Z., Shi, C., and Zhao, S.: Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells. J Neurooncol 2011))
152. Nowis, D., Bugajski, M., Winiarska, M., Bil, J., Szokalska, A., Salwa, P., Issat, T., Was, H., Jozkowicz, A., Dulak, J., Stoklosa, T., and Golab, J.: Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice. BMC Cancer 8, 197-2008))
153. Sass, G., Leukel, P., Schmitz, V., Raskopf, E., Ocker, M., Neureiter, D., Meissnitzer, M., Tasika, E., Tannapfel, A., and Tiegs, G.: Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int J Cancer 123, 1269-1277 (2008))
154. Hirai, K., Sasahira, T., Ohmori, H., Fujii, K., and Kuniyasu, H.: Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer 120, 500-505 (2007)) (Pubitemid 44969019)
155. Hill M, Pereira V, Chauveau C, Zagani R, Remy S, Tesson L, Mazal D, Ubillos L, Brion R, Asgar K, Mashreghi MF, Kotsch K, Moffett J, Doebis C, Seifert M, Boczkowski J, Osinaga E, and Anegon I: Heme oxygenase- 1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB 19, 1957-1968 (2005)) (Pubitemid 41759741)
156. Bando, H., Weich, H. A., Brokelmann, M., Horiguchi, S., Funata, N., Ogawa, T., and Toi, M.: Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer. Br J Cancer 92, 553-561 (2005)) (Pubitemid 40395537)
157. Ferrara, N., Frantz, G., LeCouter, J., llard-Telm, L., Pham, T., Draksharapu, A., Giordano, T., and Peale, F.: Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol 162, 1881-1893 (2003)) (Pubitemid 36613046)
158. Toi, M., Matsumoto, T., and Bando, H.: Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2, 667-673 (2001)) (Pubitemid 33085812)
159. Viloria-Petit, A., Miquerol, L., Yu, J. L., Gertsenstein, M., Sheehan, C., May, L., Henkin, J., Lobe, C., Nagy, A., Kerbel, R. S., and Rak, J.: Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors. EMBO J 22, 4091-4102 (2003)) (Pubitemid 37021738)
160. Sabbah, M., Emami, S., Redeuilh, G., Julien, S., Prevost, G., Zimber, A., Ouelaa, R., Bracke, M., De, Wever O., and Gespach, C.: Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11, 123-151 (2008))
161. Rak, J., Yu, J. L., Klement, G., and Kerbel, R. S.: Oncogenes and angiogenesis: signaling three-dimensional tumor growth. J Investig Dermatol Symp Proc 5, 24-33 (2000)) (Pubitemid 32044086)
162. Hanahan, D. and Folkman, J.: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996)) (Pubitemid 26272076)
163. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N.: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844 (1993)) (Pubitemid 23132159)
164. Hurwitz, H. I., Fehrenbacher, L., Hainsworth, J. D., Heim, W., Berlin, J., Holmgren, E., Hambleton, J., Novotny, W. F., and Kabbinavar, F.: Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 23, 3502-3508 (2005))
165. Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., and Johnson, D. H.: Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355, 2542-2550 (2006)) (Pubitemid 44917502)
166. Baka, S., Clamp, A. R., and Jayson, G. C.: A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis. Expert Opin Ther Targets 10, 867-876 (2006)) (Pubitemid 44816749)
167. Goumans, M. J., Liu, Z., and ten, Dijke P.: TGF-beta signaling in vascular biology and dysfunction. Cell Res 19, 116-127 (2009))
168. Sanchez-Elsner, T., Botella, L. M., Velasco, B., Corbi, A., Attisano, L., and Bernabeu, C.: Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276, 38527-38535 (2001))
169. Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordon-Cardo, C., Guise, T. A., and Massague, J.: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549 (2003)) (Pubitemid 36808649)
170. Masuyama, H., Nakatsukasa, H., Takamoto, N., and Hiramatsu, Y.: Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. J Clin Endocrinol Metab 92, 2672-2679 (2007)) (Pubitemid 47037375)
171. Criswell, T. L., Dumont, N., Barnett, J. V., and Arteaga, C. L.: Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells. Cancer Res 68, 7304-7312 (2008))
172. Lee, S. H., Mizutani, N., Mizutani, M., Luo, Y., Zhou, H., Kaplan, C., Kim, S. W., Xiang, R., and Reisfeld, R. A.: Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer. Cancer Immunol Immunother 55, 1565-1574 (2006)) (Pubitemid 44327844)
173. Roberts, A. B. and Wakefield, L. M.: The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A 100, 8621-8623 (2003)) (Pubitemid 36899145)
174. Akhurst, R. J. and Derynck, R.: TGF-beta signaling in cancer - a double-edged sword. Trends Cell Biol 11, S44- S51 (2001))
175. Rotello, R. J., Lieberman, R. C., Purchio, A. F., and Gerschenson, L. E.: Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. Proc Natl Acad Sci U S A 88, 3412-3415 (1991)) (Pubitemid 21916631)
176. Patel, P., Varghese, E., Ding, G., Fan, S., Kapasi, A., Reddy, K., Franki, N., Nahar, N., and Singhal, P.: Transforming growth factor beta induces mesangial cell apoptosis through NO- and p53-dependent and - independent pathways. J Investig Med 48, 403-410 (2000))
177. Chang, C. F., Westbrook, R., Ma, J., and Cao, D.: Transforming growth factor-beta signaling in breast cancer. Front Biosci 12, 4393-4401 (2007))
178. Bierie, B., Gorska, A. E., Stover, D. G., and Moses, H. L.: TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution. J Cell Physiol 2008))
179. Levy, L. and Hill, C. S.: Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17, 41-58 (2006)) (Pubitemid 43117515)
180. Watabe, Tetsuro and Miyazono, Kohei: Roles of TGF- [beta] family signaling in stem cell renewal and differentiation. Cell Res 19, 103-115 (2000))
181. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., Campbell, L. L., Polyak, K., Brisken, C., Yang, J., and Weinberg, R. A.: The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008)) (Pubitemid 351636299)
182. Rosenzweig, Steven A. and Atreya, Hanudatta S.: Defining the pathway to insulin-like growth factor system targeting in cancer. Biochemical Pharmacology 80, 1115-1124 (2010))
183. Trichopoulos, Dimitrios, Lagiou, Pagona, and Adami, Hans Olov: Towards an integrated model for breast cancer etiology: The crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res 7, 13-17 (2005)) (Pubitemid 40214531)
184. Savarese, Todd, Strohsnitter, William, Low, Hoi, Liu, Qin, Baik, Inkyung, Okulicz, William, Chelmow, David, Lagiou, Pagona, Quesenberry, Peter, Noller, Kenneth, and Hsieh, Chung Cheng: Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Research 9, R29 (2007))
185. Baik, Inkyung, DeVito, William J., Ballen, Karen, Becker, Pamela S., Okulicz, William, Liu, Qin, Delpapa, Ellen, Lagiou, Pagona, Sturgeon, Susan, Trichopoulos, Dimitrios, Quesenberry, Peter J., and Hsieh, Chung Cheng: Association of Fetal Hormone Levels with Stem Cell Potential: Evidence for Early Life Roots of Human Cancer. Cancer Research 65, 358-363 (2005)) (Pubitemid 40070829)
186. Lagiou, P., Hsieh, C. C., Lipworth, L., Samoli, E., Okulicz, W., Troisi, R., Xu, B., Hall, P., Ekbom, A., Adami, H. O., and Trichopoulos, D.: Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk. Br J Cancer 100, 1794-1798 (2009))